Product Reports Resources Pricing Login Book a demo

Single Technologies

Biotech & Life Sciences · Stockholm, Sweden · Founded 2014

Three-dimensional DNA sequencing technology for high-throughput genomics MoreLess

Single Technologies is a Stockholm-based deep tech company founded in 2012 by Johan Strömqvist, Bengt Sahlgren, Annika Bolind Bågenholm, and Raoul Stubbe. The company originated from research at the Royal Institute of Technology (KTH) in Stockholm combined with R&D from the fiber optical grating industry. The founding team combines expertise in biophysics and fiber optics. The company is developing a disruptive 3-D Sequencing™ technology to address the scalability limitations of current flat, 2-D sequencing methods.

The core of Single Technologies' offering is its upcoming Theta platform, a sequencer that performs analysis in three dimensions, significantly increasing the parallelism and throughput of DNA sequencing. This approach unites sequencing with spatial biology, providing deeper insights into biological structures. The technology is designed to deliver more data at a lower cost, with the goal of making a $10 genome a reality, a substantial reduction from current costs. The company's business model focuses on providing this high-throughput sequencing platform to innovators, researchers, and companies in sectors like AI, pharmaceuticals, and diagnostics. It aims to generate revenue by selling large biological datasets for applications such as AI model training.

Single Technologies has secured significant funding to advance its commercialization efforts. After raising $6.1 million in a 2020 Series A round and additional funds in subsequent years, the company secured SEK 170 million in 2025, led by the European Innovation Council, to transition from development to a commercial phase. The company serves clients and partners who are developing applications in proteomics, gene editing, and spatial biology. With its technology, Single Technologies aims to empower a new generation of data-driven biological discovery and personalized medicine.

Keywords: 3D sequencing, DNA sequencing, genomics, high-throughput sequencing, spatial biology, single-molecule imaging, biotechnology, deep tech, life sciences, next-generation sequencing, omics, transcriptomics, personalized medicine, data-driven biology, gene editing, proteomics, molecular diagnostics, bioinformatics, confocal microscopy, genetic analysis

Talent graph

Single Technologies's talent

Book a demo to see the people
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Single Technologies's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
European Innovation Council
Series A 3 investors entered at this stage
Andreas Ehn
Rothesay
Ulf Landegren

Global footprint

Where Single Technologies has talent and traffic

Workforce by country
1 countries with
team presence
🇫🇮 Finland4%
1 country shown

Market sentiment

What the market is saying about Single Technologies

An AI-synthesized read of the highest-engagement posts about Single Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Single Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.